SBFM Stock Analysis: Buy, Sell, or Hold?
SBFM - Sunshine Biopharma Inc.
$2.11
-0.07 (-3.21%)
▼
5d:
-1.4%
30d:
-18.85%
90d:
+92.69%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When SBFM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SBFM shows positive signals but monitor for confirmation. Market pricing in 9.3% decline. Moderate conviction.
💡 BUY OPPORTUNITY: SBFM shows positive signals but monitor for confirmation. Market pricing in 9.3% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$3.98
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$2.47
14.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SBFM is currently trading at $2.11, which is considered fair relative to its 30-day fair value range of $1.27 to $2.66. From a valuation perspective, the stock is trading at a discount (Forward PE: 10.6) compared to its historical average (14.2). Remarkably, the market is currently pricing in an annual earnings decline of 9.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SBFM is showing sideways momentum. Immediate support is located at $0.25, while resistance sits at $3.05. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $56.00 (+2554.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SBFM is showing sideways momentum. Immediate support is located at $0.25, while resistance sits at $3.05. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $56.00 (+2554.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.27 -
$2.66
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
67.6%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.2%)
- BULLISH: Trading 2554.0% below Wall St target ($56.00)
Trading Range Analysis
30-Day Trading Range
$1.27 -
$2.66
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.25
Resistance Level
$3.05
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.55
Wall Street Target
$56.00
(+2554.0%)
Revenue Growth (YoY)
-9.1%
Profit Margin
-17.0%
Valuation Discount vs History
-9.3% cheaper
PE vs Historical
10.6 vs 14.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-9.3%
(market-implied from PE analysis)
1-Year Target
$1.91
(-9%)
2-Year Target
$1.74
(-18%)
3-Year Target
$1.57
(-25%)
3-Yr Target (if PE normalizes)
(PE: 11→14)
$2.12
(+0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.5 to 14.2
Stabilization Target:
$2.84
(+34.6%)
PE Expansion Potential:
+34.6%
Share & Embed Analysis
Last updated: July 04, 2026 2:14 PM ET
Data refreshes hourly during market hours. Next update: 3:14 PM
Data refreshes hourly during market hours. Next update: 3:14 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SBFM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$194 | 62 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 63 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 61 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 54 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$23 | 60 HOLD |
